Karlstad

• ALASCCA-A randomized double-blind placebo-controlled study with ASA treatment in colorectal cancer patients with mutations in the PI3K signa … Pending
  2024-513778-23-00 5 Colon and rectal cancer tumor stage II-III, tumor with somatic alterat
• SGLT2 inhibitor or metformin as standard treatment in early type 2 diabetes (SMARTEST) Pending
  2024-516228-33-00 6 Type 2 Diabetes
• HiHat trial Pending
  2024-519700-28-01 4 Patients with relapsing-remitting multiple sclerosis with less than 10
• Tick-Borne Encephalitis (TBE) Remdesivir Efficacy Assessment Trial (TREAT) Pending
  2025-523476-23-00 4 Tick-Borne Encephalitis (TBE)
• Efficacy and Safety of a New Formulation of Oral Cladribine Compared with Placebo in Participants with Generalized Myasthenia Gravis (MyCla … Recruiting
  2023-507746-83-00 5 2024-11-27 Generalized Myasthenia Gravis
• EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure … Recruiting
  2025-521188-11-00 5 2025-10-15 Type 2 diabetes
• A clinical phase IV trial to examine cellular and humoral immunity against measles and chickenpox in children and adolescents 0-18 years in … Recruiting
  2024-511182-10-01 6 2025-05-22 Pediatric cancer
• A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin on clinical outcomes alone and how safe it is in adu … Recruiting
  2023-506460-14-00 5 2025-05-07 Chronic kidney disease (CKD) and hypertension.
• Phase III trial of lomustine/temozolomide (TMZ) combination therapy vs. standard TMZ therapy for newly diagnosed MGMT promoter methylated gl … Recruiting
  2023-506998-35-00 5 2025-01-08 Glioblastoma
• Concomitant HPV vaccination and HPV screening for rapid elimination of HPV infection and cervical cancer in Sweden Recruiting
  2024-518857-41-00 6 2024-11-29 HPV infection and related diseases, such as cervical intraepithelial n
• Assessment of short immunotherapy after radical surgery of high-risk malignant melanoma Recruiting
  2023-509994-22-00 5 2024-11-15 cutaneous malignant melanoma
• Improved Recovery by Iron following Surgery with blood loss, a double-blind multi-centre randomized controlled phase III drug trial (the IRI … Recruiting
  2022-502776-22-00 5 2024-09-05 Anemia
• Phase III study to evaluate the effect of balcinrenone/dapagliflozin in patients with heart failure and impaired kidney function Recruiting
  2023-508162-15-00 5 2024-07-12 Chronic HF and comorbid impairment of kidney function who had a recent
• Alternative antibiotics to multidrug-resistant UTIs Recruiting
  2024-513294-41-00 6 2023-04-17 Urinary tract infection and/or bacteremia caused by extended spectrum
• SACK Recruiting
  2022-501600-10-00 5 2023-02-07 Atrial fibrillation and Chronic Kidney Disease stage 5
• OPTION – OutPatienT InductiON: Labour induction in an outpatient setting - a multicentre randomized controlled trial Recruiting
  2023-507164-39-00 6 2021-12-01 Induction of labour
• PiSCATIN - Simvastatin for the treatment of primary sclerosing cholangitis (PSC) - a randomized double-blind, placebo-controlled multicenter … Recruiting
  2024-511053-22-00 4 2020-05-04 Primary sclerosing cholangitis (PSC)
• Does metformin reduce growth rate of small abdominal aortic aneurysms? Recruiting
  2024-517387-37-00 4 2019-12-12 Small abdominal aortic aneurysm (AAA) under active surveillance; 30-49
• ProBio: An outcome-adaptive and randomised multi-arm biomarker driven study in patients with metastatic prostate cancer Recruiting
  2023-506857-40-00 5 2019-01-08 Prostate Cancer
• A randomized controlled trial with Rituximab for Psychotic disorder in adults Ended recruitment
  2024-512408-20-00 4 2024-08-27 Schizophrenia spectrum disorder (SSD)
• Ixekizumab Diabetes Intervention Trial (I-DIT) Ended recruitment
  2023-508588-58-00 4 2022-10-25 Diabetes type 1
• A Randomized Intervention, Multi-Center Study to Determine the Role of Dexamethasone eye drops against proliferative retinopathy of prematur … Ended recruitment
  2023-505318-97-00 5 2022-09-22 Retinopathy of Prematurity
• A translational RANDOMIZED phase III study exploring the effect of the addition of capecitabine to Carboplatinum based chemotherapy in early … Ended recruitment
  2022-501102-35-00 5 2019-12-02 Early triple negative breast cancer
• Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction SPIRRIT-HFpEF Ended recruitment
  2024-517448-79-00 5 2017-11-23 Heart failure with preserved ejection fraction

Showing 1–24 of 26 trials